Evidence map›Paper›PMID 29358233›Full record

ArticleRNA (New York, N.Y.)2018

The control of paramyxovirus genome hexamer length and mRNA editing.

Yusuke Matsumoto, Keisuke Ohta, Daniel Kolakofsky, Machiko Nishio

Open access · bronzeAbstract read
In one paragraph

Article in RNA (New York, N.Y.), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Yusuke MatsumotoDepartment of Microbiology, School of Medicine, Wakayama Medical University, Wakayama 641-8509, Japan.ORCID 0000-0003-3500-2279
Keisuke OhtaDepartment of Microbiology, School of Medicine, Wakayama Medical University, Wakayama 641-8509, Japan.
Daniel KolakofskyDepartment of Microbiology and Molecular Medicine, University of Geneva School of Medicine, 1211 Geneva, Switzerland.
Machiko NishioDepartment of Microbiology, School of Medicine, Wakayama Medical University, Wakayama 641-8509, Japan.
Wakayama Medical University · JPUniversity of Geneva · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The unusual ability of a human parainfluenza virus type 2 (hPIV2) nucleoprotein point mutation (NP

Indexed as

AnimalsBinding SitesCell LineCricetinaeGenome, ViralHumansNucleoproteinsParainfluenza Virus 2, HumanPoint MutationPromoter Regions, GeneticRNA-Binding MotifsRNA-Dependent RNA PolymeraseRNA EditingRNA, MessengerRNA, ViralVirus ReplicationNucleoproteinsRNA-Dependent RNA PolymeraseRNA, MessengerRNA, Viralbipartite replication promotershuman parainfluenza virus type 2nucleoproteinparamyxoviruses

Identifiers

PMID29358233
PMCPMC5855947
OpenAlexW2789900509

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.